Imagine having to choose between going to work sick or losing a day's pay. For many Americans, that's still the reality. A recent survey looked at how many US workers have access to paid sick leave—a basic benefit that lets you stay home when you're ill without financial penalty. The data shows a modest improvement: in 2009, about 58% of employed adults had this protection. By 2018, that number had inched up to roughly 62%. That's a small but meaningful shift over nearly a decade. It's important to understand what this survey can and can't tell us. It simply counted how many people reported having paid sick leave; it didn't test any specific policy or program to see what caused the increase. The data comes from surveys, not a controlled experiment, so we can't say for sure what's driving the change—whether it's new laws, company policies, or shifts in the types of jobs available. Also, the survey only covers people who are currently employed, so it doesn't reflect the experience of those looking for work or who are out of the labor force. While the trend is moving in the right direction, the fact remains that in 2018, nearly four out of every ten workers still lacked paid sick leave. That's a lot of people who might feel pressured to work through illness, potentially putting their own health and their coworkers' at risk.
Access to paid sick leave increased among U.S. workers from 2009 to 2018, survey findsMore US workers now have paid sick leave, but many still don't
AI-generated summary of the cited source, checked by automated accuracy review. How we work
A survey report analyzed observational data on access to paid sick leave among currently employed adults in the United States. The study measured the percentage of workers with access as the primary outcome, comparing figures from 2009 and 2018. No specific intervention, comparator, or sample size was reported for this descriptive analysis.
The main result showed the percentage of currently employed workers with access to paid sick leave increased from 57.8% in 2009 to 62.4% in 2018. No effect size, absolute numbers, p-values, or confidence intervals were reported for this change. The direction was described as an increase over this period.
No safety, adverse events, or tolerability data were reported, as this was a survey of access, not a clinical intervention. Key limitations include the observational nature of survey data, which prevents causal inference, and uncertain generalizability beyond the specific U.S. employed adult population studied. Statistical significance of the change was not reported. The practice relevance is limited to providing descriptive context about workforce benefits; clinicians should recognize this as population-level trend data rather than evidence for clinical decision-making.
View Original Abstract ↓
Intrawound tobramycin plus vancomycin did not reduce deep infection risk compared with vancomycin alone in high-risk tibial fractures
Adding Antibiotics to Bone Surgery Didn't Lower Infection Risk
Related in Infectious Disease
From Other Specialties
